Key facts
- It has raised $164.1M; the latest was Later Stage VC ($60.7M) in Sep 2025.
- Notable investors include Novo Holdings, E.R. Capital, AT Newtec, Athos (Family Office), Cargill — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for AMSilk
- ·The full record, as it builds
Funding rounds
No funding rounds for AMSilk are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About AMSilk
Manufacturer of bio-degradable polymers intended to innovate bio-fabricated plant-based raw materials at industrial quantities. The company uses its patented biotechnological process, biotech material based on silk proteins that can be converted into usable forms such as powders, hydrogels and fibers and the bio-fabricated materials are fully biodegradable under aerobic and marine conditions, enabling users to make smart performing biotech materials part of everyday life.
- Sector
- Materials and Resources
- HQ
- Neuried, Germany
- Founded
- 2006
- Employees
- 81
- Website
- amsilk.com/
- Ownership
- Privately Held (backing)
AMSilk doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in AMSilk shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on AMSilk in its N-PORT filings yet. We sweep new filings monthly.